1-naphthylamine has been researched along with Panic Attacks in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gupta, AK; Gupta, MA | 1 |
Gorman, JM; Greenberg, HE; Klein, DF; Papp, LA; Rifkin, A; Scharf, SM; Weiss, JR | 1 |
Settle, EC | 1 |
Zinner, SH | 1 |
Bakish, D; Joffe, RT | 1 |
Harnett-Sheehan, K; Sheehan, DV | 1 |
Labbate, LA; Oleshansky, MA | 1 |
Yonkers, KA | 1 |
Bouwer, CD; Hawkridge, SM; Stein, DJ | 1 |
Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
Gorman, JM | 1 |
Apter, JT | 1 |
Clary, CM; Rapaport, MH; Wolkow, RM | 1 |
Clary, CM; Pohl, RB; Wolkow, RM | 1 |
4 review(s) available for 1-naphthylamine and Panic Attacks
Article | Year |
---|---|
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Methodologies and outcomes from the sertraline multicenter flexible-dose trials.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Panic Disorder; Sertraline | 1998 |
2 trial(s) available for 1-naphthylamine and Panic Attacks
Article | Year |
---|---|
Combined SSRI-moclobemide treatment of psychiatric illness.
Topics: 1-Naphthylamine; Adult; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
Topics: 1-Naphthylamine; Adult; Agoraphobia; Ambulatory Care; Comorbidity; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
8 other study(ies) available for 1-naphthylamine and Panic Attacks
Article | Year |
---|---|
Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants?
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Female; Fluoxetine; Humans; Middle Aged; Panic Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Urticaria | 1995 |
Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders.
Topics: 1-Naphthylamine; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Lung Diseases, Obstructive; Panic Disorder; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Akathisia and sertraline.
Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Depressive Disorder; Female; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 1993 |
Panic attacks precipitated by sertraline.
Topics: 1-Naphthylamine; Adult; Humans; Male; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Inability to cry during SRI treatment.
Topics: 1-Naphthylamine; Adult; Crying; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1996 |
Exacerbation of respiratory symptoms in patients with panic disorder.
Topics: 1-Naphthylamine; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cilazapril; Citalopram; Comorbidity; Drug Interactions; Female; Humans; Hypertension; Male; Middle Aged; Panic Disorder; Respiration Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Evolving treatment of panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Counseling; Health Education; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |